Trial Profile
Safety and Immunogenicity of Adacel Vaccine Administered to Persons 10 Years of Age.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors Sanofi; Sanofi Pasteur
- 30 Apr 2012 Actual patient number 1302 added as reported by ClinicalTrials.gov.
- 30 Apr 2012 Actual end date (January 2012) added as reported by ClinicalTrials.gov.
- 30 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.